Showing results (421-430 of 870) with videos related to
Sort By:
Pageof 87
Surgery Today|January 1, 1996
Pseudointimal hyperplasia of ridged outer wall polytetrafluoroethylene vascular prosthesesT Shibuya, J Kambayashi, D I Kim, et al.Geroscience|February 12, 2025
Adipose chemokine ligand CX3CL1 contributes to maintaining the hippocampal BDNF level, and the effect is attenuated in advanced ageYoshinori Takei, Yoko Amagase, Ai Goto, et al.Thrombosis and Haemostasis|August 9, 2006
Ex vivo evaluation of anti-GPVI antibody in cynomolgus monkeys: dissociation between anti-platelet aggregatory effect and bleeding timeYutaka Matsumoto, Hisao Takizawa, Kazuhiro Nakama, et al.Journal of Leukocyte Biology|July 9, 2015
TCR signaling intensity controls CD8+ T cell responsiveness to TGF-βVidhyalakshmi Arumugam, Theresa Bluemn, Erin Wesley, et al.Case Reports in Oncology|March 9, 2018
Successful Treatment of Erythrodermic Mycosis Fungoides with Mogamulizumab Followed by Etoposide MonotherapyTaku Fujimura, Kayo Tanita, Yota Sato, et al.American Journal of Physiology. Endocrinology and Metabolism|March 8, 2007
Activation of AMP-activated protein kinase stimulates proopiomelanocortin gene transcription in AtT20 corticotroph cellsYasumasa Iwasaki, Mitsuru Nishiyama, Takafumi Taguchi, et al.The Journal of Dermatology|April 16, 2020
Severe pyrexia from nivolumab-resistant advanced melanoma after successful combined therapy with encorafenib plus binimetinibRyo Amagai, Taku Fujimura, Yumi Kambayashi, et al.Case Reports in Oncology|April 21, 2020
Successful Treatment of a Patient with anti-PD1 Antibody-Resistant Advanced Mucosal Melanoma with Nivolumab, Ipilimumab plus Denosumab Combination TherapyTaku Fujimura, Yumi Kambayashi, Kentaro Ohuchi, et al.British Journal of Pharmacology|May 27, 2017
The anaesthetized rabbit with acute atrioventricular block provides a new model for detecting drug-induced Torsade de PointesMihoko Hagiwara, Seiji Shibuta, Kazuhiro Takada, et al.The British Journal of Dermatology|April 18, 2018
Three patients with advanced cutaneous angiosarcoma treated with eribulin: investigation of serum soluble CD163 and chemokine (C-X-C motif) ligand 10 as possible biomarkers predicting the biological behaviour of angiosarcomaT Fujimura, Y Sato, Y Kambayashi, et al.Pageof 87